Prostaglandin E2 promotes the survival of bone marrow-derived dendritic cells

Journal of Immunology

Volumn 173, Issue 11, 2004, Pages 6955-6964

  Vassiliou, Evros ^a   Sharma, Vikas ^a   Jing, Huie ^a   Sheibanie, Farzad ^a   Ganea, Doina ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTAPROST; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CASPASE 3; CERAMIDE; GROWTH FACTOR; IBUPROFEN; MISOPROSTOL; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROTEIN KINASE B; SULPROSTONE; BAD PROTEIN, MOUSE; CARRIER PROTEIN; CASP3 PROTEIN, MOUSE; CASPASE; GROWTH INHIBITOR; LIPOPOLYSACCHARIDE; PROTEIN BAD;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL MATURATION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; LYMPH NODE; MALE; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; A J MOUSE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MEMBRANE POTENTIAL; CYTOLOGY; DRUG ANTAGONISM; ENZYME ACTIVATION; ENZYMOLOGY; IMMUNOLOGY; INTRACELLULAR MEMBRANE; METABOLISM; MITOCHONDRION; PHYSIOLOGY; TRANSPLANTATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BONE MARROW CELLS; CARRIER PROTEINS; CASPASE 3; CASPASES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; DINOPROSTONE; ENZYME ACTIVATION; GROWTH INHIBITORS; IBUPROFEN; INTRACELLULAR MEMBRANES; LIPOPOLYSACCHARIDES; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED A; MICE, INBRED C57BL; MITOCHONDRIA; RECEPTORS, PROSTAGLANDIN E;

EID: 9144249046     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.11.6955     Document Type: Article

References (40)

1. Kaisho, T., and S. Akira. 2003. Regulation of dendricic cell function through Toll-like receptors. Curr. Mol. Med. 3:759.
2. Lipscomb, M. F., and B. J. Masten. 2002. Dendritic cells: immune regulators in health and disease. Physiol. Rev. 82:97.
3. Moll, H. 2003. Dendritic cells and host resistance to infection. Cell Microbiol. 5:493.
4. Ozato, K., H. Tsujimura, and T. Tamura. 2002. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. BioTechniques 66(Suppl. 8):70.
5. Rescigno, M. 2002. Dendritic cells and the complexity of microbial infection. Trends Microbiol. 10:425.
6. Underhill, D. M. 2003, Toll-like receptors: networking for success. Eur. J. Immunol. 33:1767.
7. Hayakawa, Y., V. Screpanti, H. Yagita, A. Grandien, H. G. Ljunggren, M. J. Smyth, and B. J. Chambers. 2004. NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J. Immunol. 172:123.
8. + T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J. Immunol. 164:3095.
9. + Vα24 natural killer T cells expressing CD40L. Immunology 102:137.
10. Ritchie, D. S., I. F. Hermans, J. M. Lumsden, C. B. Scanga, J. M. Roberts, J. Yang, R. A. Kemp, and F. Ronchese. 2000. Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo. J. Immunol. Methods 246:109.
11. Kim, K. D., Y. K. Choe, I. S. Choe, and J. S. Lim. 2001. Inhibition of glucocorticoid-mediated, caspase-independent dendritic cell death by CD40 activation. J. Leukocyte Biol. 69:426.
12. Nicolo, C., B. Tomassini, M. R. Rippo, and R. Testi. 2001. UVB-induced apoptosis of human dendritic cells: contribution by caspase-dependent and caspase-independent pathways. Blood 97:1803.
13. Bertho, N., B. Laupeze, N. Mooney, C. Le Berre, D. Charron, B. Drenou, and R. Fauchet. 2001. HLA-DR mediated cell death is associated with, but not induced by TNF-α secretion in APC. Hum. Immunol. 62:106.
14. Bertho, N., V. M. Blancheteau, N. Setterblad, B. Laupeze, J. M. Lord, B. Drenou, L. Amiot, D. J. Charron, R. Fauchet, and N. Mooney. 2002. MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-δ isoenzyme. Int. Immunol. 14:935.
15. Leverkus, M., A. D. McLellan, M. Heldmann, A. O. Eggert, E. B. Brocker, N. Koch, and E. Kampgen. 2003. MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways. Int. Immunol. 15:993.
16. Ashany, D., A. Savir, A., N. Bhardwaj, and K. B. Elkon. 1999. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. J. Immunol. 163:5303.
17. Hoves, S., S. W. Krause, D. Halbritter, H. G. Zhang, J. D. Mountz, J. Scholmerich, and M. Fleck. 2003. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC. J. Immunol. 170:5406.
18. Leverkus, M., H. Walczak, A. McLellan, H. W. Fries, G. Terbeck, E. B. Brocker, and E. Kampgen. 2000. Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis. Blood 96:2628.
19. L. Cancer Immunol. Immunother. 51:139.
20. McLellan, A. D., G. Terbeck, T. Mengling, G. C. Starling, P. A. Kiener, R. Gold, E. B. Brocker, M. Leverkus, and E. Kampgen. 2000. Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development. Cell Death Differ. 7:933.
21. Rocca, B., and G. A. FitzGerald. 2002. Cyclooxygenases and prostaglandins: shaping up the immune response. Int. Immunopharmacol. 2:603.
22. Jonuleit, H., U. Kuhn, G. Muller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop, and A. H. Enk. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27:3135.
23. 2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159:28.
24. 2 regulates the migratory capacity of specific DC subsets. Blood 100:1362.
25. 2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100:1354.
26. 2. Blood 103:1595.
27. 2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9:744.
28. 2 receptors in the pathogenesis of rheumatoid arthritis. J. Clin. Invest. 110:651.
29. Jozefowski, S., M. Bobek, and J. Marcinkiewicz. 2003. Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved. Int. Immunopharmacol. 3:865.
30. 2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cell. Immunol. 223:120.
31. 2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells. J. Leukocyte Biol. 74:868.
32. 2 up-regulates macrophage-derived chemokine production but suppresses IFN-inducible protein-10 production by APC. J. Immunol. 166:1650.
33. Narumiya, S., Y. Sugimoto, and F. Ushikubi. 1999. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79:1193.
34. Aabakken, L., J. H. Dybdahl, W. Eidsaunet, A. Haaland, S. Larsen, and M. Osnes. 1989. Optimal assessment of gastrointestinal side effects induced by nonsteroidal anti-inflammatory drugs: endoscopic lesions, faecal blood loss, and symptoms not necessarily correlated, as observed after naproxen and oxindanac in healthy volunteers. Scand. J. Gastroenterol. 24:1007.
35. Tilley, S. L., T. M. Coffman, and B. H. Koller. 2001. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108:15.
36. Martin-Fontecha, A., S. Sebastiani, U. E. Hopken, M. Uguccioni, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198:615.
37. Regan, J. W. 2003. EP2 and EP4 prostanoid receptor signaling. Life Sci. 74:143.
38. Mei, F. C., J. Qiao, O. M. Tsygankova, J. L. Meinkoth, L. A. Quilliam, and X. Cheng. 2002. Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation. J. Biol. Chem. 277:11497.
39. Alessi, D. R., and P. Cohen. 1998. Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev. 8:55.
40. Nunez, G., and L. del Peso. 1998. Linking extracellular survival signals and the apoptotic machinery. Curr. Opin. Neurobiol. 8:613.